Fig. 3From: DNA methylation changes in response to neoadjuvant chemotherapy are associated with breast cancer survivalPathway analysis of the differentially methylated CpG sites in the four genomic regions with significant findings (gene body CGIs, gene body non-CGIs, promoter CGIs and promoter non-CGIs) in 5-year survivors. Sites with loss of methylation are predominantly enriched for terms related to sequence-specific DNA binding, cell adhesion and the plasma membrane, while many of the sites with a gain in methylation are enriched for terms related to the immune response. The size of the dots represents the -log10 of the FDR of overrepresentation, and the color indicates if the sites related to the term had gained (blue) or lost (red) methylation. CGI = CpG islandBack to article page